Interleukin enhancer-binding factor 3

BE0014107ProteinHumansILF3

RNA-binding protein that plays an essential role in the biogenesis of circular RNAs (circRNAs) which are produced by back-splicing circularization of pre-mRNAs. It is acted on by 1 drug in DrugBank.

Gene name
ILF3
UniProtKB entry
Q12906Swiss-Prot
Cellular location
Nucleus, nucleolus
Residues / weight
894 residues · 95,338 Da
Also known as
Double-stranded RNA-binding protein 76 · DRBF · DRBP76 · M-phase phosphoprotein 4 · MPHOSPH4

Resolves to

Protein
UniProtQ12906UniProt nameILF3_HUMAN
Gene
HGNCHGNC:6038NCBI Gene3609GeneCardsILF3
Pharmacology
KEGGhsa:3609
Structure
PDB2L33PDB3P1XPDB7RJM
Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Interleukin enhancer-binding factor 3, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In